(Q41970879)

14 October 2017

title

Duration of Protection by Inhaled Salmeterol in Exercise-induced Asthma (English)

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

Cardiology and cardiovascular medicine

28 October 2022

main subject

asthma

0 references

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

28 October 2022

author name string

S. D. Anderson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682113

28 October 2022

L. T. Rodwell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682113

28 October 2022

J. Du Toit

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682113

28 October 2022

I. H. Young

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682113

28 October 2022

language of work or name

English

0 references

publication date

1 November 1991

1 reference

full work available at URL

14 October 2017

https://api.elsevier.com/content/article/PII:S0012369216336716?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

https://api.elsevier.com/content/article/PII:S0012369216336716?httpAccept=text/plain

28 October 2022

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

28 October 2022

1 reference

14 October 2017

volume

100

1 reference

14 October 2017

issue

5

1 reference

14 October 2017

page(s)

1254-1260

1 reference

14 October 2017

cites work

Exercise-induced asthma.

1

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

An evaluation of pharmacotherapy for exercise-induced asthma

28 October 2022

3

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

The duration of protection from exercise-induced asthma by inhaled salbutamol, and a comparison with inhaled reproterol

28 October 2022

5

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

The duration of action of the combination of fenoterol hydrobromide and ipratropium bromide in protecting against asthma provoked by hyperpnea

28 October 2022

7

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

Duration of protective effect of terbutaline sulfate and cromolyn sodium alone and in combination on exercise-induced asthma

28 October 2022

8

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

Inhaled and oral bronchodilator therapy in exercise induced asthma

28 October 2022

9

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

Fenoterol in exercise-induced asthma. Effect of dose on efficacy and duration of action

28 October 2022

10

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

Bronchoconstriction stimulated by airway cooling. Better protection with combined inhalation of terbutaline sulphate and cromolyn sodium than with either alone

28 October 2022

11

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

Deep inspiration increases the absorption of inhaled sodium cromoglycate

28 October 2022

14

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

On the predictive value of experiments in vitro in the evaluation of the effect duration of bronchodilator drugs for local administration

28 October 2022

15

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients

28 October 2022

16

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

Spirometric standards for healthy nonsmoking adults

28 October 2022

18

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

Arterial plasma histamine levels at rest, and during and after exercise in patients with asthma: effects of terbutaline aerosol

28 October 2022

24

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

Basic pharmacology of new long-acting sympathomimetics

28 October 2022

26

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

Effect of catecholamines on ion transport in dog tracheal epithelium

28 October 2022

29

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

Postexertional airway rewarming and thermally induced asthma. New insights into pathophysiology and possible pathogenesis

28 October 2022

30

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

Heat and water loss from the airways and exercise-induced asthma

28 October 2022

32

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

Sensitivity to heat and water loss at rest and during exercise in asthmatic patients.

28 October 2022

33

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

Hypothesis: exercise-induced asthma as a vascular phenomenon

28 October 2022

34

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

Is there a unifying hypothesis for exercise-induced asthma?

28 October 2022

35

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

Issues in exercise-induced asthma

28 October 2022

36

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells

28 October 2022

37

1 reference

https://api.crossref.org/works/10.1378/CHEST.100.5.1254

28 October 2022

Identifiers

1 reference

14 October 2017

1 reference